U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07926074) titled 'AI Chatbot Mobile App for Self-Management in Type 2 Diabetes' on Nov. 03.
Brief Summary: Type 2 diabetes needs daily self-management, but most of it happens outside the clinic, where patients get little continuous support. Earlier studies of mobile applications and chatbots were mostly short, and few tested whether benefits last after use stops. This randomized controlled trial will test an Arabic-language mobile application with an artificial intelligence chatbot for adults with type 2 diabetes attending outpatient diabetes clinics in Egypt. The application offers diabetes education, reminders, glucose and activity logging, goal se...